<table class="drug-table data-table table table-condensed table-bordered"><tbody><tr id="identification"><th class="divider" colspan="2">Identification</th></tr><tr><th>Name</th><td><strong>Theophylline</strong></td></tr><tr><th>Accession Number</th><td><strong>DB00277</strong>&#160; (APRD00082)</td></tr><tr><th>Type</th><td>small molecule</td></tr><tr><th>Groups</th><td>approved</td></tr><tr><th>Description</th><td><p>A methylxanthine derivative from tea with diuretic, smooth muscle relaxant, bronchial dilation, cardiac and central nervous system stimulant activities. Mechanistically, theophylline acts as a phosphodiesterase inhibitor, adenosine receptor blocker, and histone deacetylase activator. Theophylline is marketed under several brand names such as Uniphyl and Theochron, and it is indicated mainly for asthma, bronchospasm, and <span class="caps">COPD</span>.</p></td></tr><tr><th>Structure</th><td><div class="structure"><a class="moldbi-thumbnail" href="http://structures.wishartlab.com/molecules/DB00277/image.png"><img alt="Thumb" src="http://structures.wishartlab.com/molecules/DB00277/thumb.png"></a></div><div class="structure-links"><div class="btn-group btn-group-xs"><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00277.mol">MOL</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00277.sdf">SDF</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00277.pdb">PDB</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00277.smiles">SMILES</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00277.inchi">InChI</a><a class="btn btn-info" href="/structures/structures/small_molecule_drugs/DB00277">View Structure</a></div></div></td></tr><tr><th>Synonyms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="synonyms"><thead><th>Synonym</th><th>Language</th><th>Code</th></thead><tbody><tr><td>1,3-dimethyl-7H-purine-2,6-dione</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>1,3-dimethylxanthine</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Theophyllin</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Theophylline Anhydrous</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr></tbody></table></td></tr><tr><th>Salts</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Brand names</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="brands"><thead><tr><th>Name</th><th>Company</th></tr></thead><tbody><tr><td>Elixophyllin</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Quibron-T</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Respbid</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Slo-Bid</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Theo 24</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Theo-24</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Theo-Dur</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Theodur G</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Theolair</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Theophylline(Anhydrous)</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Uniphyl</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr></tbody></table></td></tr><tr><th>Brand mixtures</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="mixtures"><thead><tr><th>Brand Name</th><th>Ingredients</th></tr></thead><tbody><tr><td>Bronchyl Syrup</td><td>alcohol anhydrous + beechwood creosote + cocillana + eucalyptus + guaiacol oleate + ipecac + lobelia inflata + menthol + myroxylon balsamum + theophylline + white pine</td></tr><tr><td>Choledyl Expectorant Elixir</td><td>guaifenesin + oxtriphylline</td></tr><tr><td>Diuerb tab</td><td>oil of fleabane + theophylline + urea</td></tr><tr><td>IDM Expectorant tab</td><td>guaifenesin + potassium iodide + pyrilamine maleate + theophylline</td></tr><tr><td>IDM tab</td><td>potassium iodide + pyrilamine maleate + theophylline</td></tr><tr><td>PMS-Oxtriphylline Elixir</td><td>alcohol anhydrous + oxtriphylline</td></tr><tr><td>Pulmo Septol Sirop</td><td>beechwood creosote + cocillana + eucalyptus oil + guaiacol + ipecac + lobelia inflata + myroxylon balsamum + theophylline + white pine</td></tr><tr><td>Ratio-theo-bronc</td><td>guaifenesin + potassium iodide + pyrilamine maleate + theophylline</td></tr><tr><td>Tedral tab</td><td>l-ephedrine hydrochloride + phenobarbital + theophylline</td></tr></tbody></table></td></tr><tr><th>Categories</th><td><ul><li><a href="/mesh/phosphodiesterase-inhibitors">Phosphodiesterase Inhibitors</a></li>
<li><a href="/mesh/purinergic-p1-receptor-antagonists">Purinergic P1 Receptor Antagonists</a></li>
<li><a href="/mesh/bronchodilator-agents">Bronchodilator Agents</a></li>
<li><a href="/mesh/vasodilator-agents">Vasodilator Agents</a></li>
<li><a href="/mesh/muscle-relaxants-respiratory">Muscle Relaxants, Respiratory</a></li></ul></td></tr><tr><th>CAS number</th><td>58-55-9</td></tr><tr><th>Weight</th><td>Average: 180.164<br>Monoisotopic: 180.06472552</td></tr><tr><th>Chemical Formula</th><td>C<sub>7</sub>H<sub>8</sub>N<sub>4</sub>O<sub>2</sub></td></tr><tr><th>InChI Key</th><td>ZFXYFBGIUFBOJW-UHFFFAOYSA-N</td></tr><tr><th>InChI</th><td><div class="wrap">InChI=1S/C7H8N4O2/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13/h3H,1-2H3,(H,8,9)</div></td></tr><tr><th>IUPAC Name</th><td><div class="wrap">1,3-dimethyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione</div></td></tr><tr><th>SMILES</th><td><div class="wrap">CN1C2=C(NC=N2)C(=O)N(C)C1=O</div></td></tr><tr><th>Mass Spec</th><td><a href="/system/mass_specs/DB00277.gif?1265922774">show</a>(2.96 KB)</td></tr><tr id="taxonomy"><th class="divider" colspan="2">Taxonomy</th></tr><tr><th>Kingdom</th><td>Organic Compounds</td></tr><tr><th>Superclass</th><td>Heterocyclic Compounds</td></tr><tr><th>Class</th><td>Imidazopyrimidines</td></tr><tr><th>Subclass</th><td>Purines and Purine Derivatives</td></tr><tr><th>Direct parent</th><td>Xanthines</td></tr><tr><th>Alternative parents</th><td>Purinones; Pyrimidones; Imidazoles; Polyamines</td></tr><tr><th>Substituents</th><td>pyrimidone; pyrimidine; imidazole; azole; polyamine; amine; organonitrogen compound</td></tr><tr><th>Classification description</th><td>This compound belongs to the xanthines. These are purine derivatives with a ketone group conjugated at carbons 2 and 6 of the purine moiety.</td></tr><tr id="pharmacology"><th class="divider" colspan="2">Pharmacology</th></tr><tr><th>Indication</th><td>For the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, such as emphysema and chronic bronchitis.</td></tr><tr><th>Pharmacodynamics</th><td>Theophylline, an xanthine derivative chemically similar to caffeine and theobromine, is used to treat asthma and bronchospasm. Theophylline has two distinct actions in the airways of patients with reversible (asthmatic) obstruction; smooth muscle relaxation (i.e., bronchodilation) and suppression of the response of the airways to stimuli (i.e., non-bronchodilator prophylactic effects).</td></tr><tr><th>Mechanism of action</th><td>Theophylline relaxes the smooth muscle of the bronchial airways and pulmonary blood vessels and reduces airway responsiveness to histamine, methacholine, adenosine, and allergen. Theophylline competitively inhibits type III and type IV phosphodiesterase (PDE), the enzyme responsible for breaking down cyclic AMP in smooth muscle cells, possibly resulting in bronchodilation. Theophylline also binds to the adenosine A2B receptor and blocks adenosine mediated bronchoconstriction. In inflammatory states, theophylline activates histone deacetylase to prevent transcription of inflammatory genes that require the acetylation of histones for transcription to begin.</td></tr><tr><th>Absorption</th><td>Theophylline is rapidly and completely absorbed after oral administration in solution or immediate-release solid oral dosage form.</td></tr><tr><th>Volume of distribution</th><td><ul>
	<li>0.3 to 0.7 L/kg</li>
</ul></td></tr><tr><th>Protein binding</th><td>40%, primarily to albumin.</td></tr><tr><th>Metabolism</th><td class="data-table-container"><p>Hepatic. Biotransformation takes place through demethylation to 1-methylxanthine and 3-methylxanthine and hydroxylation to 1,3-dimethyluric acid. 1-methylxanthine is further hydroxylated, by xanthine oxidase, to 1-methyluric acid. About 6% of a theophylline dose is N-methylated to caffeine. Caffeine and 3-methylxanthine are the only theophylline metabolites with pharmacologic activity.</p><table class="table-standard table-condensed" id="experimental-properties"><thead><tr><th>Substrate</th><th>Enzymes</th><th colspan="2">Product</th></tr></thead><tbody><tr><td>Theophylline</td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><ul><li><a href="/biodb/bio_entities/BE0002433" target="_blank">Cytochrome P450 1A2</a></li></ul></td><td><a href="/metabolites/DBMET00271">1-Methylxanthine</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/272">Details</a></td></tr><tr><td>Theophylline</td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><ul><li><a href="/biodb/bio_entities/BE0002433" target="_blank">Cytochrome P450 1A2</a></li></ul></td><td><a href="/metabolites/DBMET00272">3-methylxanthine</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/273">Details</a></td></tr><tr><td>Theophylline</td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><ul><li><a href="/biodb/bio_entities/BE0003533" target="_blank">Cytochrome P450 2E1</a></li></ul></td><td><a href="/metabolites/DBMET00326">1,3-dimethyluric acid</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/327">Details</a></td></tr><tr><td>Theophylline</td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><span class="wishart wishart-not-available">Not Available</span></td><td><a href="/metabolites/DBMET00535">Caffeine</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/550">Details</a></td></tr></tbody></table></td></tr><tr><th>Route of elimination</th><td>Theophylline does not undergo any appreciable pre-systemic elimination, distributes freely into fat-free tissues and is extensively metabolized in the liver. Renal excretion of unchanged theophylline in neonates amounts to about 50% of the dose, compared to about 10% in children older than three months and in adults.</td></tr><tr><th>Half life</th><td>8 hours</td></tr><tr><th>Clearance</th><td><ul>
	<li>0.29 mL/kg/min [Premature neonates,  postnatal age 3-15 days]</li>
	<li>0.64 mL/kg/min [Premature neonates,  postnatal age 25-57 days]</li>
	<li>1.7 mL/kg/min [Children 1-4 years]</li>
	<li>1.6 mL/kg/min [Children 4-12 years]</li>
	<li>0.9 mL/kg/min [Children 13-15 years]</li>
	<li>1.4 mL/kg/min [Children 16-17 years]</li>
	<li>0.65 mL/kg/min [Adults (16-60 years), otherwise healthy non-smoking asthmatics]</li>
	<li>0.41 mL/kg/min [Elderly (&gt;60 years), non-smokers with normal cardiac, liver, and renal function]</li>
	<li>0.33 mL/kg/min [Acute pulmonary edema]</li>
	<li>0.54 mL/kg/min [<span class="caps">COPD</span> &gt;60 years, stable, non-smoker &gt;1 year]</li>
	<li>0.48 mL/kg/min [<span class="caps">COPD</span> with cor pulmonale]</li>
	<li>1.25 mL/kg/min [Cystic fibrosis (14-28 years)]</li>
	<li>0.31 mL/kg/min [Liver disease cirrhosis]</li>
	<li>0.35 mL/kg/min [acute hepatitis]</li>
	<li>0.65 mL/kg/min [cholestasis]</li>
	<li>0.47 mL/kg/min [Sepsis with multi-organ failure]</li>
	<li>0.38 mL/kg/min [hypothyroid]</li>
	<li>0.8 mL/kg/min [hyperthyroid]</li>
</ul></td></tr><tr><th>Toxicity</th><td>Symptoms of overdose include seizures, arrhythmias, and GI effects.</td></tr><tr><th>Affected organisms</th><td><ul><li>Humans and other mammals</li></ul></td></tr><tr><th>Pathways</th><td class="data-table-container"><table class="table table-condensed table-striped" id="pathways"><thead><tr><th>Pathway</th><th>Category</th><th>SMPDB ID</th></tr></thead><tbody><tr><td>Caffeine Metabolism</td><td>Metabolic</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00028?highlight%5Bcompounds%5D%5B%5D=DB00277&amp;highlight%5Bproteins%5D%5B%5D=DB00277">SMP00028</a></td></tr></tbody></table></td></tr><tr><th>SNP Mediated Effects</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="snp-fx"><thead><tr><th>Interacting Gene/Enzyme</th><th>SNP RS ID</th><th>Allele name</th><th>Defining change</th><th>Effect</th><th>Reference(s)</th></tr></thead><tbody><tr><td>Cytochrome P450 1A2<br>Gene symbol: CYP1A2<br>UniProt: <a class="wishart-link-out" href="http://www.uniprot.org/uniprot/P05177" target="_blank">P05177 <span class="glyphicon glyphicon-new-window"> </span></a></td><td><span class="wishart wishart-not-available">Not Available</span></td><td>-2964(G/A)</td><td>A Allele</td><td>Poor metabolizer, lower dose requirement</td><td><span class="citation"><a class="pubmed-link wishart-link-out" data-toggle="tooltip" href="http://www.ncbi.nlm.nih.gov/pubmed/12732846" target="_blank" title="Obase Y, Shimoda T, Kawano T, Saeki S, Tomari SY, Mitsuta-Izaki K, Matsuse H, Kinoshita M, Kohno S: Polymorphisms in the CYP1A2 gene and theophylline metabolism in patients with asthma. Clin Pharmacol Ther. 2003 May;73(5):468-74.">12732846 <span class="glyphicon glyphicon-new-window"> </span></a></span></td></tr></tbody></table></td></tr><tr><th>SNP Mediated Adverse Drug Reactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="admet"><th class="divider" colspan="2">ADMET</th></tr><tr><th>Predicted ADMET features</th><td class="data-table-container"><table class="table table-condensed table-striped" id="predicted-admet">
  <thead>
    <tr>
      <th>Property</th>
      <th>Value</th>
      <th>Probability</th>
    </tr>
  </thead>
  <tbody>
      <tr>
        <td>Human Intestinal Absorption</td>
        <td>
              +
        </td>
        <td>1.0</td>
      </tr>
      <tr>
        <td>Blood Brain Barrier</td>
        <td>
              +
        </td>
        <td>0.9902</td>
      </tr>
      <tr>
        <td>Caco-2 permeable</td>
        <td>
              +
        </td>
        <td>0.6172</td>
      </tr>
      <tr>
        <td>P-glycoprotein substrate</td>
        <td>
            Non-substrate
        </td>
        <td>0.7281</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor I</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.8939</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor II</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.911</td>
      </tr>
      <tr>
        <td>Renal organic cation transporter</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.8807</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-substrate</td>
        <td>0.7738</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-substrate</td>
        <td>0.9117</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Non-substrate</td>
        <td>0.5974</td>
      </tr>
      <tr>
        <td>CYP450 1A2 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9045</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9933</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9827</td>
      </tr>
      <tr>
        <td>CYP450 2C19 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9895</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9616</td>
      </tr>
      <tr>
        <td>CYP450 inhibitory promiscuity</td>
        <td>Low CYP Inhibitory Promiscuity</td>
        <td>0.9956</td>
      </tr>
      <tr>
        <td>Ames test</td>
        <td>
          Non AMES toxic 
        </td>
        <td>
            0.9132
        </td>
      </tr>
      <tr>
        <td>Carcinogenicity</td>
        <td>
          Non-carcinogens 
        </td>
        <td>
            0.9447
        </td>
      </tr>
      <tr>
        <td>Biodegradation</td>
        <td>
          Ready biodegradable 
        </td>
        <td>
            0.5942
        </td>
      </tr>
      <tr>
        <td>Rat acute toxicity</td>
        <td>
          2.7898 
            LD50, mol/kg
        </td>
        <td>
            <span class="wishart wishart-not-available">Not applicable</span>
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor I)</td>
        <td>
          Weak inhibitor 
        </td>
        <td>
            0.8819
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor II)</td>
        <td>
          Non-inhibitor 
        </td>
        <td>
            0.8927
        </td>
      </tr>
  </tbody>
</table>
</td></tr><tr id="pharmacoeconomics"><th class="divider" colspan="2">Pharmacoeconomics</th></tr><tr><th>Manufacturers</th><td><ul><li>Fleming and co pharmaceuticals inc</li>
<li>Forest laboratories inc</li>
<li>Sanofi aventis us llc</li>
<li>Dm graham laboratories inc</li>
<li>Ucb inc</li>
<li>Whitby pharmaceuticals inc</li>
<li>Schwarz pharma inc</li>
<li>Schering corp</li>
<li>Central pharmaceuticals inc</li>
<li>Hospira inc</li>
<li>Inwood laboratories inc sub forest laboratories inc</li>
<li>Sandoz inc</li>
<li>Rp scherer north america div rp scherer corp</li>
<li>Ortho mcneil pharmaceutical inc</li>
<li>Schering corp sub schering plough corp</li>
<li>Fisons corp</li>
<li>Kv pharmaceutical co</li>
<li>Rp scherer north america</li>
<li>Hr cenci laboratories inc</li>
<li>Caraco pharmaceutical laboratories ltd</li>
<li>Lannett co inc</li>
<li>Panray corp sub ormont drug and chemical co inc</li>
<li>Alpharma us pharmaceuticals division</li>
<li>Cenci powder products inc</li>
<li>Halsey drug co inc</li>
<li>L perrigo co</li>
<li>Pharmaceutical assoc inc div beach products</li>
<li>Precision dose inc</li>
<li>Roxane laboratories inc</li>
<li>Taro pharmaceuticals usa inc</li>
<li>Wockhardt eu operations (swiss) ag</li>
<li>B braun medical inc</li>
<li>Baxter healthcare corp</li>
<li>3m pharmaceuticals inc</li>
<li>Ferndale laboratories inc</li>
<li>Warner chilcott co llc</li>
<li>Monarch pharmaceuticals inc</li>
<li>Roerig div pfizer inc</li>
<li>Able laboratories inc</li>
<li>Glenmark generics ltd</li>
<li>Nostrum pharmaceuticals inc</li>
<li>Pliva inc</li>
<li>Pharmaceutical research assoc inc</li>
<li>Purdue pharmaceutical products lp</li>
<li>Graceway pharmaceuticals llc</li>
<li>Novartis consumer health inc</li></ul></td></tr><tr><th>Packagers</th><td><ul><li><a href="http://www.actavis.com">Actavis Group</a></li>
<li>Amend</li>
<li><a href="http://www.americanregent.com">American Regent</a></li>
<li><a href="http://www.amerisourcebergen.com">Amerisource Health Services Corp.</a></li>
<li><a href="http://www.amneal.com">Amneal Pharmaceuticals</a></li>
<li>Apotheca Inc.</li>
<li>Arcola Laboratories</li>
<li><a href="http://orders.a-smeds.com">A-S Medication Solutions LLC</a></li>
<li><a href="http://www.atlanticbiologicals.com">Atlantic Biologicals Corporation</a></li>
<li><a href="http://www.bbraun.com">B. Braun Melsungen AG</a></li>
<li><a href="http://BASF%20Corp.">BASF Corp.</a></li>
<li><a href="http://www.baxter.com">Baxter International Inc.</a></li>
<li><a href="http://www.bms.com">Bristol-Myers Squibb Co.</a></li>
<li>C.O. Truxton Inc.</li>
<li><a href="http://www.cardinal.com">Cardinal Health</a></li>
<li><a href="http://www.caremark.com">Caremark LLC</a></li>
<li><a href="http://www.chcsct.com">Central Texas Community Health Centers</a></li>
<li>Comprehensive Consultant Services Inc.</li>
<li>Direct Dispensing Inc.</li>
<li><a href="http://www.drxdispensing.com">Dispensing Solutions</a></li>
<li><a href="http://www.dhscorp.com">Diversified Healthcare Services Inc.</a></li>
<li><a href="http://www.emcure.co.in">Emcure Pharmaceuticals Ltd.</a></li>
<li>Equipharm Inc.</li>
<li><a href="http://www.frx.com">Forest Laboratories Inc.</a></li>
<li><a href="http://www.forestpharm.com">Forest Pharmaceuticals</a></li>
<li><a href="http://www.glenmark-generics.com">Glenmark Generics Ltd.</a></li>
<li><a href="http://www.hhlabs.com">H and H Laboratories</a></li>
<li>Heartland Repack Services LLC</li>
<li><a href="http://www.hospira.com">Hospira Inc.</a></li>
<li><a href="http://www.inwoodlabs.com">Inwood Labs</a></li>
<li>Inyx Usa Ltd.</li>
<li>Kaiser Foundation Hospital</li>
<li><a href="http://www.luitpold.com">Luitpold Pharmaceuticals Inc.</a></li>
<li><a href="http://www.majorpharmaceuticals.com">Major Pharmaceuticals</a></li>
<li>Marlop Pharmaceuticals Inc.</li>
<li><a href="http://www.mckesson.com">Mckesson Corp.</a></li>
<li><a href="http://www.mundipharma.net">Mundipharma GmbH</a></li>
<li><a href="http://www.unitdosesupply.com">Murfreesboro Pharmaceutical Nursing Supply</a></li>
<li><a href="http://www.nostrumlabs.com">Nostrum Laboratories Inc.</a></li>
<li><a href="http://www.nucarerx.com">Nucare Pharmaceuticals Inc.</a></li>
<li>P F Laboratories Inc.</li>
<li>PCA LLC</li>
<li><a href="http://www.pdrx.com">PD-Rx Pharmaceuticals Inc.</a></li>
<li><a href="http://www.pfizer.com">Pfizer Inc.</a></li>
<li>Pharmaceutical Packaging Center</li>
<li>Pharmaceutical Utilization Management Program VA Inc.</li>
<li><a href="http://www.pharmedixrx.com">Pharmedix</a></li>
<li><a href="http://www.physicianstotalcare.com">Physicians Total Care Inc.</a></li>
<li><a href="http://www.pliva.com">Pliva Inc.</a></li>
<li>Prepackage Specialists</li>
<li><a href="http://www.prepaksys.com">Prepak Systems Inc.</a></li>
<li><a href="http://www.purduepharma.com">Purdue Pharma LP</a></li>
<li><a href="http://www.worldoftest.com">Qualitest</a></li>
<li><a href="http://www.remedyrepack.com">Remedy Repack</a></li>
<li><a href="http://www.riteaid.com">Rite Aid Corp.</a></li>
<li><a href="http://www.roxane.com">Roxane Labs</a></li>
<li>Roxmar Laboratories</li>
<li><a href="http://www.sandhillspackaging.com">Sandhills Packaging Inc.</a></li>
<li><a href="http://www.sandoz.ca">Sandoz</a></li>
<li><a href="http://www.sanofi-aventis.com">Sanofi-Aventis Inc.</a></li>
<li><a href="http://www.southwoodhealthcare.com">Southwood Pharmaceuticals</a></li>
<li>Talbert Medical Management Corp.</li>
<li><a href="http://www.tarousa.com">Taro Pharmaceuticals USA</a></li>
<li>Tya Pharmaceuticals</li>
<li><a href="http://www.ucb.com">UCB Pharma</a></li>
<li><a href="http://www.urlpharma.com">United Research Laboratories Inc.</a></li>
<li>Vangard Labs Inc.</li>
<li>Warrick Pharmaceuticals Corp.</li>
<li><a href="http://www.wockhardtin.com">Wockhardt Ltd.</a></li></ul></td></tr><tr><th>Dosage forms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="dosages"><thead><tr><th>Form</th><th>Route</th><th>Strength</th></tr></thead><tbody><tr><td>Elixir</td><td>Oral</td><td></td></tr><tr><td>Liquid</td><td>Oral</td><td></td></tr><tr><td>Solution</td><td>Intravenous</td><td></td></tr><tr><td>Tablet</td><td>Oral</td><td></td></tr><tr><td>Tablet, extended release</td><td>Oral</td><td></td></tr></tbody></table></td></tr><tr><th>Prices</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="prices"><thead><tr><th>Unit description</th><th>Cost</th><th>Unit</th></tr></thead><tbody><tr><td>Elixophyllin GG 100-100 mg/15ml Solution 240ml Bottle</td><td>60.98USD</td><td>bottle</td></tr><tr><td>Uniphyl 600 mg 24 Hour tablet</td><td>2.28USD</td><td>tablet</td></tr><tr><td>Theo-24 400 mg 24 Hour Capsule</td><td>2.04USD</td><td>capsule</td></tr><tr><td>Theo-24 400 mg capsule sa</td><td>1.97USD</td><td>capsule</td></tr><tr><td>Uniphyl 400 mg 24 Hour tablet</td><td>1.58USD</td><td>tablet</td></tr><tr><td>Theo-24 300 mg 24 Hour Capsule</td><td>1.45USD</td><td>capsule</td></tr><tr><td>Theo-24 300 mg capsule sa</td><td>1.4USD</td><td>capsule</td></tr><tr><td>Theophylline 400 mg 24 Hour tablet</td><td>1.27USD</td><td>tablet</td></tr><tr><td>Theo-24 200 mg 24 Hour Capsule</td><td>1.25USD</td><td>capsule</td></tr><tr><td>Theo-24 200 mg capsule sa</td><td>1.14USD</td><td>capsule</td></tr><tr><td>Theochron 450 mg tablet sa</td><td>0.94USD</td><td>tablet</td></tr><tr><td>Theophylline CR 300 mg 12 Hour Capsule</td><td>0.93USD</td><td>capsule</td></tr><tr><td>Theo-24 100 mg 24 Hour Capsule</td><td>0.83USD</td><td>capsule</td></tr><tr><td>Theophylline CR 200 mg 12 Hour Capsule</td><td>0.79USD</td><td>capsule</td></tr><tr><td>Theophylline CR 450 mg 12 Hour tablet</td><td>0.79USD</td><td>tablet</td></tr><tr><td>Theo-24 100 mg capsule sa</td><td>0.76USD</td><td>capsule</td></tr><tr><td>Quibron 90-150 mg capsule</td><td>0.73USD</td><td>capsule</td></tr><tr><td>Theophylline CR 125 mg 12 Hour Capsule</td><td>0.73USD</td><td>capsule</td></tr><tr><td>Uniphyl 600 mg Sustained-Release Tablet</td><td>0.68USD</td><td>tablet</td></tr><tr><td>Uniphyl 400 mg Sustained-Release Tablet</td><td>0.56USD</td><td>tablet</td></tr><tr><td>Theochron 300 mg tablet sa</td><td>0.54USD</td><td>tablet</td></tr><tr><td>Theophylline CR 300 mg 12 Hour tablet</td><td>0.51USD</td><td>tablet</td></tr><tr><td>Theophylline CR 200 mg 12 Hour tablet</td><td>0.4USD</td><td>tablet</td></tr><tr><td>Theochron 200 mg tablet sa</td><td>0.33USD</td><td>tablet</td></tr><tr><td>Theophylline CR 100 mg 12 Hour tablet</td><td>0.3USD</td><td>tablet</td></tr><tr><td>Elixophyllin GG 100-100 mg/15ml Solution</td><td>0.24USD</td><td>ml</td></tr><tr><td>Theochron 100 mg tablet sa</td><td>0.23USD</td><td>tablet</td></tr><tr><td>Elixophyllin 80 mg/15ml Elixir</td><td>0.2USD</td><td>ml</td></tr><tr><td>Elixophyllin 80 mg/15 ml elix</td><td>0.19USD</td><td>ml</td></tr><tr><td>Apo-Theo La 300 mg Sustained-Release Tablet</td><td>0.15USD</td><td>tablet</td></tr><tr><td>Apo-Theo La 100 mg Sustained-Release Tablet</td><td>0.14USD</td><td>tablet</td></tr><tr><td>Apo-Theo La 200 mg Sustained-Release Tablet</td><td>0.14USD</td><td>tablet</td></tr><tr><td>Theophylline anhydrous powder</td><td>0.08USD</td><td>g</td></tr><tr><td>Theophylline 200 mg/100 ml d5w</td><td>0.06USD</td><td>ml</td></tr><tr><td>Theolair 5.3 mg/ml Liquid</td><td>0.03USD</td><td>ml</td></tr></tbody></table><div class="alert alert-warning clearfix">DrugBank does not sell nor buy drugs. Pricing information is supplied for informational purposes only.</div></td></tr><tr><th>Patents</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="properties"><th class="divider" colspan="2">Properties</th></tr><tr><th>State</th><td>solid</td></tr><tr><th>Experimental Properties</th><td class="data-table-container"><table class="table table-condensed table-striped" id="experimental-properties"><tr><th class="head-medium">Property</th><th class="head-large">Value</th><th>Source</th></tr><tr><td>melting point</td><td>273 &#176;C</td><td>PhysProp</td></tr><tr><td>water solubility</td><td>7360 mg/L (at 25 &#176;C)</td><td>YALKOWSKY,SH &amp; HE,Y (2003)</td></tr><tr><td>logP</td><td>-0.02</td><td>HANSCH,C ET AL. (1995)</td></tr><tr><td>Caco2 permeability</td><td>-4.35</td><td>ADME Research, USCD</td></tr><tr><td>pKa</td><td>8.81</td><td>KORTUM,G ET AL (1961)</td></tr></table></td></tr><tr><th>Predicted Properties</th><td class="data-table-container"><table class="table table-condensed table-striped"><thead><tr><th class="head-medium">Property</th><th class="head-large">Value</th><th>Source</th></tr></thead><tbody><tr><td>water solubility</td><td>2.29e+01 g/l</td><td><a href="http://www.vcclab.org/lab/alogps/" target="_blank">ALOGPS</a></td></tr><tr><td>logP</td><td>-0.26</td><td><a href="http://www.vcclab.org/lab/alogps/" target="_blank">ALOGPS</a></td></tr><tr><td>logP</td><td>-0.77</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-predictors/#logp_logd">ChemAxon</a></td></tr><tr><td>logS</td><td>-0.9</td><td><a href="http://www.vcclab.org/lab/alogps/" target="_blank">ALOGPS</a></td></tr><tr><td>pKa (strongest acidic)</td><td>7.82</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-predictors/#pka">ChemAxon</a></td></tr><tr><td>pKa (strongest basic)</td><td>-0.78</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-predictors/#pka">ChemAxon</a></td></tr><tr><td>physiological charge</td><td>0</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-predictors/#pka">ChemAxon</a></td></tr><tr><td>hydrogen acceptor count</td><td>3</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#h_bond">ChemAxon</a></td></tr><tr><td>hydrogen donor count</td><td>1</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#h_bond">ChemAxon</a></td></tr><tr><td>polar surface area</td><td>69.3</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#topolgical_surface">ChemAxon</a></td></tr><tr><td>rotatable bond count</td><td>0</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#topology_analysis">ChemAxon</a></td></tr><tr><td>refractivity</td><td>44.93</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#refractivity">ChemAxon</a></td></tr><tr><td>polarizability</td><td>16.86</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>number of rings</td><td>2</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#topology_analysis">ChemAxon</a></td></tr><tr><td>bioavailability</td><td>1</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>rule of five</td><td>Yes</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>Ghose filter</td><td>No</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>Veber's rule</td><td>No</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>MDDR-like rule</td><td>No</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr></tbody></table></td></tr><tr id="spectra"><th class="divider" colspan="2">Spectra</th></tr><tr><th>Spectra</th><td><ul><li><a data-no-turbolink="true" href="/spectra/spectra/nmr_one_d/1782">1H NMR Spectrum</a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/ms_ms/1792">MS/MS Spectrum Quattro_QQQ 10</a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/ms_ms/1793">MS/MS Spectrum Quattro_QQQ 25</a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/ms_ms/1794">MS/MS Spectrum Quattro_QQQ 40</a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/ms_ms/5553">MS/MS Spectrum EI-B (Unknown) </a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/ms_ms/5554">MS/MS Spectrum CI-B (Unknown) </a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/ms_ms/5555">MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 10</a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/ms_ms/5556">MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 20</a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/ms_ms/5557">MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 30</a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/ms_ms/5558">MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 40</a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/ms_ms/5559">MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 50</a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/ms_ms/5560">MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 10</a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/ms_ms/5561">MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 20</a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/ms_ms/5562">MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 30</a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/ms_ms/5563">MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 40</a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/ms_ms/5564">MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 50</a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/nmr_two_d/1722">[1H,13C] 2D NMR Spectrum</a></li></ul></td></tr><tr id="references"><th class="divider" colspan="2">References</th></tr><tr><th>Synthesis Reference</th><td><span class="citations"><p>Nicolae S. Bodor, Kenneth B. Sloan, Yu-Neng Kuo, &#8220;Method for synthesizing certain selected pro-drug forms of theophylline.&#8221; U.S. Patent US4000132, issued January, 1956.</p></span><a class="wishart-link-out" href="https://www.google.com/?tbm=pts#q=4000132&amp;tbm=pts" target="_blank">US4000132 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><th>General Reference</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>External Links</th><td class="data-table-container"><table class="table table-condensed table-striped" id="experimental-properties"><thead><tr><th>Resource</th><th>Link</th></tr></thead><tbody><tr><td>KEGG Drug</td><td><a class="wishart-link-out" href="http://www.genome.jp/dbget-bin/www_bget?drug:D00371" target="_blank">D00371 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>KEGG Compound</td><td><a class="wishart-link-out" href="http://www.genome.jp/dbget-bin/www_bget?cpd:C07130" target="_blank">C07130 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>PubChem Compound</td><td><a class="wishart-link-out" href="http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=2153" target="_blank">2153 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>PubChem Substance</td><td><a class="wishart-link-out" href="http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=46505949" target="_blank">46505949 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>ChemSpider</td><td><a class="wishart-link-out" href="http://www.chemspider.com/Chemical-Structure.2068.html" target="_blank">2068 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>BindingDB</td><td><a class="wishart-link-out" href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10847" target="_blank">10847 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>ChEBI</td><td><a class="wishart-link-out" href="http://www.ebi.ac.uk/chebi/searchId.do?chebiId=28177" target="_blank">28177 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>ChEMBL</td><td><a class="wishart-link-out" href="http://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL190" target="_blank">CHEMBL190 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>Therapeutic Targets Database</td><td><a class="wishart-link-out" href="http://bidd.nus.edu.sg/group/cjttd/ZFTTDDRUG.asp?ID=DAP000002" target="_blank">DAP000002 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>PharmGKB</td><td><a class="wishart-link-out" href="http://www.pharmgkb.org/drug/PA451647" target="_blank">PA451647 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>IUPHAR</td><td><a class="wishart-link-out" href="http://www.iuphar-db.org/DATABASE/LigandDisplayForward?ligandId=413" target="_blank">413 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>Guide to Pharmacology</td><td><a class="wishart-link-out" href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=413" target="_blank">413 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>HET</td><td><a class="wishart-link-out" href="http://www.ebi.ac.uk/msd-srv/chempdb/cgi-bin/cgi.pl?FUNCTION=getByCode&amp;CODE=TEP" target="_blank">TEP <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>Drug Product Database</td><td><a class="wishart-link-out" href="http://205.193.93.51/dpdonline/searchRequest.do?din=627410" target="_blank">627410 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>RxList</td><td><a class="wishart-link-out" href="http://www.rxlist.com/cgi/generic/theosr.htm" target="_blank">http://www.rxlist.com/cgi/generic/theosr.htm <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>Drugs.com</td><td><a class="wishart-link-out" href="http://www.drugs.com/cdi/theophylline.html" target="_blank">http://www.drugs.com/cdi/theophylline.html <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>PDRhealth</td><td><a class="wishart-link-out" href="http://www.pdrhealth.com/drug_info/rxdrugprofiles/drugs/the1440.shtml" target="_blank">http://www.pdrhealth.com/drug_info/rxdrugprofiles/drugs/the1440.shtml <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>Wikipedia</td><td><a class="wishart-link-out" href="http://en.wikipedia.org/wiki/Theophylline" target="_blank">Theophylline <span class="glyphicon glyphicon-new-window"> </span></a></td></tr></tbody></table></td></tr><tr><th>ATC Codes</th><td>R03DA04<ul class="atc-drug-tree"><li><a href="/atc/R#R">R &#8212; RESPIRATORY SYSTEM</a></li><li><a href="/atc/R03#R03">R03 &#8212; DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES</a></li><li><a href="/atc/R03D#R03D">R03D &#8212; OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES</a></li><li><a href="/atc/R03DA#R03DA">R03DA &#8212; Xanthines</a></li></ul>R03DA05<ul class="atc-drug-tree"><li><a href="/atc/R#R">R &#8212; RESPIRATORY SYSTEM</a></li><li><a href="/atc/R03#R03">R03 &#8212; DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES</a></li><li><a href="/atc/R03D#R03D">R03D &#8212; OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES</a></li><li><a href="/atc/R03DA#R03DA">R03DA &#8212; Xanthines</a></li></ul></td></tr><tr><th>AHFS Codes</th><td><ul><li>86:16.00</li></ul></td></tr><tr><th>PDB Entries</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>FDA label</th><td><a href="/system/fda_labels/DB00277.pdf?1265922804">show</a>(85.2 KB)</td></tr><tr><th>MSDS</th><td><a href="/system/msds/DB00277.pdf?1265922742">show</a>(75.1 KB)</td></tr><tr id="interactions"><th class="divider" colspan="2">Interactions</th></tr><tr><th>Drug Interactions</th><td class="data-table-container"><table class="table table-condensed table-striped" id="experimental-properties"><thead><tr><th>Drug</th><th style="width: 75%"></th></tr></thead><tbody><tr><td><a href="/drugs/DB00787">Aciclovir</a></td><td>Acyclovir may increase the effect and toxicity of theophylline.</td></tr><tr><td><a href="/drugs/DB00640">Adenosine</a></td><td>Theophylline may decrease the effect of adenosine.</td></tr><tr><td><a href="/drugs/DB01351">Amobarbital</a></td><td>The barbiturate, amobarbital, decreases the effect of theophylline.</td></tr><tr><td><a href="/drugs/DB01352">Aprobarbital</a></td><td>The barbiturate, aprobarbital, decreases the effect of theophylline.</td></tr><tr><td><a href="/drugs/DB00732">Atracurium</a></td><td>Theophylline decreases the effect of the muscle relaxant</td></tr><tr><td><a href="/drugs/DB01558">Bromazepam</a></td><td>Theophylline may decrease the therapeutic effect of bromazepam. Monitor for changes in the therapeutic effects of bromazepam if theophylline is initiated, discontinued or dose changed. </td></tr><tr><td><a href="/drugs/DB00237">Butabarbital</a></td><td>The barbiturate, butabarbital, decreases the effect of theophylline.</td></tr><tr><td><a href="/drugs/DB00241">Butalbital</a></td><td>The barbiturate, butalbital, decreases the effect of theophylline.</td></tr><tr><td><a href="/drugs/DB01353">Butethal</a></td><td>The barbiturate, butethal, decreases the effect of theophylline.</td></tr><tr><td><a href="/drugs/DB00564">Carbamazepine</a></td><td>Carbamazepine may decrease the serum concentration of theophylline. Theophylline may decrease the serum concentration of carbamazepine. Monitor for changes in the therapeutic effect of both agents if concomitant therapy is initiated, discontinued or dose changed.</td></tr><tr><td><a href="/drugs/DB00521">Carteolol</a></td><td>Antagonism of action and increased effect of theophylline</td></tr><tr><td><a href="/drugs/DB00501">Cimetidine</a></td><td>Cimetidine may increase the effect of theophylline.</td></tr><tr><td><a href="/drugs/DB00537">Ciprofloxacin</a></td><td>Ciprofloxacin may increase the effect of theophylline.</td></tr><tr><td><a href="/drugs/DB01211">Clarithromycin</a></td><td>Clarithromycin may increase the therapeutic and adverse effects of theophylline.</td></tr><tr><td><a href="/drugs/DB01341">Dihydroquinidine barbiturate</a></td><td>The barbiturate, dihydroquinidine barbiturate, decreases the effect of theophylline.</td></tr><tr><td><a href="/drugs/DB00822">Disulfiram</a></td><td>Disulfiram may increase the effect and toxicity of theophylline.</td></tr><tr><td><a href="/drugs/DB01135">Doxacurium chloride</a></td><td>Theophylline decreases the effect of the muscle relaxant</td></tr><tr><td><a href="/drugs/DB00467">Enoxacin</a></td><td>Enoxacin may increase the effect of theophylline.</td></tr><tr><td><a href="/drugs/DB00199">Erythromycin</a></td><td>The macrolide, erythromycin, may increase the effect and toxicity of theophylline.</td></tr><tr><td><a href="/drugs/DB00977">Ethinyl Estradiol</a></td><td>The contraceptive increases the effect and toxicity of theophylline</td></tr><tr><td><a href="/drugs/DB00754">Ethotoin</a></td><td>Decreased effect of both products</td></tr><tr><td><a href="/drugs/DB04854">Febuxostat</a></td><td>Coadministration of febuxostat with xanthine oxidase substrate drugs (azathioprine, mercaptopurine or theophylline) could increase plasma concentrations of these drugs, since these drugs are metabolized by xanthine oxidase, resulting in severe toxicity; hence their concomitant use is contraindicated. Since febuxostat does not inhibit or induce cytochrome P450 enzymes it lacks significant drug interactions with other drugs metabolized of these enzymes.</td></tr><tr><td><a href="/drugs/DB00176">Fluvoxamine</a></td><td>Fluvoxamine may increase the therapeutic and adverse effects of theophylline.</td></tr><tr><td><a href="/drugs/DB01320">Fosphenytoin</a></td><td>Decreased effect of both products</td></tr><tr><td><a href="/drugs/DB00365">Grepafloxacin</a></td><td>Grepafloxacin may increase the effect of theophylline.</td></tr><tr><td><a href="/drugs/DB01159">Halothane</a></td><td>Increased risk of cardiac arrhythmia</td></tr><tr><td><a href="/drugs/DB01354">Heptabarbital</a></td><td>The barbiturate, heptabarbital, decreases the effect of theophylline.</td></tr><tr><td><a href="/drugs/DB01355">Hexobarbital</a></td><td>The barbiturate, hexobarbital, decreases the effect of theophylline.</td></tr><tr><td><a href="/drugs/DB00034">Interferon Alfa-2a, Recombinant</a></td><td>Interferon increases the effect and toxicity of theophylline</td></tr><tr><td><a href="/drugs/DB00105">Interferon Alfa-2b, Recombinant</a></td><td>Interferon increases the effect and toxicity of theophylline</td></tr><tr><td><a href="/drugs/DB00011">Interferon alfa-n1</a></td><td>Interferon increases the effect and toxicity of theophylline</td></tr><tr><td><a href="/drugs/DB00951">Isoniazid</a></td><td>Isoniazid may increase the therapeutic and adverse effects of theophylline.</td></tr><tr><td><a href="/drugs/DB01321">Josamycin</a></td><td>The macrolide, josamycin, may increase the effect and toxicity of theophylline.</td></tr><tr><td><a href="/drugs/DB01356">Lithium</a></td><td>Theophylline decreases serum levels of lithium</td></tr><tr><td><a href="/drugs/DB00532">Mephenytoin</a></td><td>Decreased effect of both products</td></tr><tr><td><a href="/drugs/DB01357">Mestranol</a></td><td>The contraceptive increases the effect and toxicity of theophylline</td></tr><tr><td><a href="/drugs/DB00474">Methohexital</a></td><td>The barbiturate, methohexital, decreases the effect of theophylline.</td></tr><tr><td><a href="/drugs/DB00849">Methylphenobarbital</a></td><td>The barbiturate, methylphenobarbital, decreases the effect of theophylline.</td></tr><tr><td><a href="/drugs/DB01336">Metocurine</a></td><td>Theophylline decreases the effect of the muscle relaxant</td></tr><tr><td><a href="/drugs/DB00379">Mexiletine</a></td><td>Mexiletine increases the effect and toxicity of theophylline</td></tr><tr><td><a href="/drugs/DB01226">Mivacurium</a></td><td>Theophylline decreases the effect of the muscle relaxant</td></tr><tr><td><a href="/drugs/DB01203">Nadolol</a></td><td>Antagonism of action and increased effect of theophylline</td></tr><tr><td><a href="/drugs/DB01059">Norfloxacin</a></td><td>Norfloxacin may increase the effect of theophylline.</td></tr><tr><td><a href="/drugs/DB01337">Pancuronium</a></td><td>Theophylline decreases the effect of the muscle relaxant</td></tr><tr><td><a href="/drugs/DB00487">Pefloxacin</a></td><td>Pefloxacin may increase the effect of theophylline.</td></tr><tr><td><a href="/drugs/DB00008">Peginterferon alfa-2a</a></td><td>Interferon increases the effect and toxicity of theophylline</td></tr><tr><td><a href="/drugs/DB00022">Peginterferon alfa-2b</a></td><td>Interferon increases the effect and toxicity of theophylline</td></tr><tr><td><a href="/drugs/DB01359">Penbutolol</a></td><td>Antagonism of action and increased effect of theophylline</td></tr><tr><td><a href="/drugs/DB00312">Pentobarbital</a></td><td>The barbiturate, pentobarbital, decreases the effect of theophylline.</td></tr><tr><td><a href="/drugs/DB00806">Pentoxifylline</a></td><td>Pentoxifylline increases the effect and toxicity of theophylline</td></tr><tr><td><a href="/drugs/DB01174">Phenobarbital</a></td><td>The barbiturate, phenobarbital, decreases the effect of theophylline.</td></tr><tr><td><a href="/drugs/DB00252">Phenytoin</a></td><td>Decreased effect of both products</td></tr><tr><td><a href="/drugs/DB00960">Pindolol</a></td><td>Antagonism of action and increased effect of theophylline</td></tr><tr><td><a href="/drugs/DB00794">Primidone</a></td><td>The barbiturate, primidone, decreases the effect of theophylline.</td></tr><tr><td><a href="/drugs/DB01182">Propafenone</a></td><td>Propafenone increases the effect of theophylline</td></tr><tr><td><a href="/drugs/DB00571">Propranolol</a></td><td>Antagonism of action and increased effect of theophylline</td></tr><tr><td><a href="/drugs/DB01346">Quinidine barbiturate</a></td><td>The barbiturate, quinidine barbiturate, decreases the effect of theophylline.</td></tr><tr><td><a href="/drugs/DB06213">Regadenoson</a></td><td>Non-specific adenosine receptor antagonist may interfere with the vasodilation activity of regadenoson. Avoid methylxanthines for at least 12 hours before administration of regadenoson. </td></tr><tr><td><a href="/drugs/DB01045">Rifampicin</a></td><td>Rifampin decreases the effect of theophylline</td></tr><tr><td><a href="/drugs/DB00503">Ritonavir</a></td><td>Ritonavir decreases the effect of theophylline</td></tr><tr><td><a href="/drugs/DB00533">Rofecoxib</a></td><td>Rofecoxib increases the effect and toxicity of theophylline</td></tr><tr><td><a href="/drugs/DB00418">Secobarbital</a></td><td>The barbiturate, secobarbital, decreases the effect of theophylline.</td></tr><tr><td><a href="/drugs/DB00489">Sotalol</a></td><td>Antagonism of action and increased effect of theophylline</td></tr><tr><td><a href="/drugs/DB01323">St. John's Wort</a></td><td>St. John's Wort decreases the effect of theophylline</td></tr><tr><td><a href="/drugs/DB00382">Tacrine</a></td><td>Tacrine may reduce the elimination rate of Theophylline. Monitor for changes in the therapeutic and toxic effects of theophylline if Tacrine is initiated, discontinued or if the dose is changed.</td></tr><tr><td><a href="/drugs/DB00306">Talbutal</a></td><td>The barbiturate, talbutal, decreases the effect of theophylline.</td></tr><tr><td><a href="/drugs/DB00976">Telithromycin</a></td><td>Telithromycin may reduce clearance of Theophylline. Consider alternate therapy or monitor for changes in the therapeutic/adverse effects of Theophylline if Telithromycin is initiated, discontinued or dose changed.</td></tr><tr><td><a href="/drugs/DB00231">Temazepam</a></td><td>Theophylline may decrease the efficacy of Temazepam. Monitor for changes in the therapeutic effect of Temazepam if Theophylline is initiated, discontinued or dose changed. </td></tr><tr><td><a href="/drugs/DB00857">Terbinafine</a></td><td>Terbinafine increases the effect and toxicity of theophylline</td></tr><tr><td><a href="/drugs/DB00730">Thiabendazole</a></td><td>The strong CYP1A2 inhibitor, Thiabendazole, may increase the effects and toxicity of Theophylline by decreasing Theophylline metabolism and clearance. Monitor for changes in the therapeutic and adverse effects of Theophylline if Thiabendazole is initiated, discontinued or dose changed.</td></tr><tr><td><a href="/drugs/DB00208">Ticlopidine</a></td><td>Ticlopidine increases the effect and toxicity of theophylline</td></tr><tr><td><a href="/drugs/DB00373">Timolol</a></td><td>Antagonism of action and increased effect of theophylline</td></tr><tr><td><a href="/drugs/DB00932">Tipranavir</a></td><td>Tipranavir, co-administered with Ritonavir, may decrease the concentration of Theophylline. </td></tr><tr><td><a href="/drugs/DB01361">Troleandomycin</a></td><td>The macrolide, troleandomycin, may increase the effect and toxicity of theophylline.</td></tr><tr><td><a href="/drugs/DB01199">Tubocurarine</a></td><td>Theophylline decreases the effect of the muscle relaxant</td></tr><tr><td><a href="/drugs/DB01339">Vecuronium</a></td><td>Theophylline decreases the effect of the muscle relaxant</td></tr><tr><td><a href="/drugs/DB00661">Verapamil</a></td><td>Verapamil increases the effect of theophylline</td></tr><tr><td><a href="/drugs/DB00582">Voriconazole</a></td><td>Voriconazole, a strong CYP3A4 inhibitor, may increase the serum concentration of theophylline by decreasing its metabolism. Monitor for changes in the therapeutic and adverse effects of theophylline if voriconazole is initiated, discontinued or dose changed.</td></tr><tr><td><a href="/drugs/DB00549">Zafirlukast</a></td><td>Zafirlukast serum concentrations may be decreased by Theophylline.</td></tr><tr><td><a href="/drugs/DB00744">Zileuton</a></td><td>Zileuton may increase the therapeutic and adverse effects of theophylline by increasing its serum concentration. Monitor for changes in the therapeutic and adverse effects of theophylline if zileuton is initiated, discontinued or dose changed. Dose alterations should be considered.</td></tr></tbody></table></td></tr><tr><th>Food Interactions</th><td><ul><li>Avoid alcohol.</li>
<li>Avoid excessive quantities of coffee or tea (Caffeine).</li>
<li>Take with food.</li></ul></td></tr></tbody></table>